Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02730104 · ClinicalTrials.gov registry record
Community-based Neuroendocrine Tumor (NET) Research Study
A clinical trial, sponsored by Ipsen.
- Completed
- Registry status
- 100
- Enrollment target
NCT02730104 is a clinical trial that has completed, run by Ipsen. The registered enrollment target is 100 participants.
The verdict
NCT02730104 has completed, sponsored by Ipsen.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
Study Summary
The purpose of this trial is to assess time to disease progression of patients with locally advanced or metastatic gastroenteropancreatic neuroendocrine tumors treated with Lanreotide Depot. This is an observational study therefore all data collected will be in accordance with the routine practice of physicians.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2015-11-23 |
| Est. Completion | 2020-05-13 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02730104
The ClinicalTrials.gov registry entry for NCT02730104 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ipsen, which has 85 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02730104 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02730104 about?
NCT02730104 is a clinical study titled "Community-based Neuroendocrine Tumor (NET) Research Study". The purpose of this trial is to assess time to disease progression of patients with locally advanced or metastatic gastroenteropancreatic neuroendocrine tumors treated with Lanreotide Depot. This is an observational study therefore all data collected will be in accordance with the routine practice o...
What is the current status of trial NCT02730104?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2015-11-23. Estimated completion is 2020-05-13.
Who is sponsoring clinical trial NCT02730104?
This trial is sponsored by Ipsen, which has 85 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.